A study of mice led by Ohio
University Heritage College of Osteopathic Medicine and Edison Biotechnology
Institute researchers has shown that stopping the activity of growth hormone
(GH) in fat cells can improve health and increase lifespan.
Growth hormone is best known for
regulating growth; however, its presence has both beneficial and detrimental
effects. It is found in many tissues in the body and plays an important role in
numerous biological functions including aging.
The concept for the study was inspired
in part by a mouse that set a record for being the longest-lived in a
laboratory. This long-lived mouse has no growth hormone action in any cell or
tissue, resulting in mice that were small in size and obese but with a much
longer lifespan than typical laboratory mice. Investigators wanted to see if
selectively removing GH receptor from fat cells (adipocytes), rather than
entirely removing it from the body, would retain the beneficial aspects of GH
insensitivity while limiting the more harmful effects.
“This study expands our knowledge about
the action of GH and how it can specifically impact different tissues with
different physiological outcomes,” said John Kopchick, Ph.D., who collaborated
on the study with Ohio University investigators Edward List, Ph.D., and Darlene
Berryman, Ph.D., along with researchers at Dalhousie University in Nova Scotia.
“Although in this study the mice have increased fat, they were metabolically
healthy and lived longer than control littermates, meaning that we can apply
this to our own lives helping the general public understand that not all fat is
bad fat.”
The results, which were
recently published in the journal, Endocrinology, where it received the distinction of a Featured
Article, showed that disrupting the growth hormone receptor (GHR)
gene in fat cells improved insulin sensitivity at an advanced age and increased
lifespan in male mice. The mice also had increased fat mass, reduced
circulating levels of insulin, C-peptide, adiponectin, resistin, and improved
frailty scores with increased grip strength at advanced ages. The researchers
found that approximately 23% lifespan extension in male mice that have no GH
action is due to GHR disruption in fat cells. In a previous report, they
determined that approximately 19% of the lifespan extension is due to GH action
in muscle, and that females benefited less from GHR disruption.
The study was conceived as investigators
considered a line of mice developed in Kopchick’s lab here at Ohio University
that has been used for more than 25 years to study healthy aging. This line of
mice, called growth hormone receptor knockout (GHRKO) mice, have no GH action
in their bodies. They live longer, have enhanced insulin sensitivity and are
protected from multiple age-related diseases.
“In fact, this mouse, which is
completely GH insensitive because it lacks the receptor for GH (GHR), holds the
record for the longest-lived laboratory mouse, living one week shy of five
years versus control mice, which live about two to two and a half years,” List
said. “We also know that GH acts on fat cells so we wanted to find out what
happens if we take away GHR only in these cells while leaving GHR intact in all
other cells and tissues.”
After removing the GH receptor in
adipocytes in mice, the investigators allowed the mice to live normally and
analyzed if the alteration impacted their metabolism and lifespan, looking at
adiposity, cytokines/adipokines, glucose homeostasis, frailty, and lifespan in
aging mice of both sexes.
According to the study, the data
demonstrate that removal of GH’s action, even in a single tissue, is sufficient
for observable health benefits that promote long-term health, reduce frailty,
and increase longevity.
“This study is important because it tells us that some of the not-so-beneficial health effects of GH occur in adipose tissue and that GH is not an anti-aging drug; if anything it promotes aging,” List said.
Journal article: https://academic.oup.com/endo/article/163/10/bqac129/6661409
No comments:
Post a Comment